Concepedia

Author

Yuhong Ning

Bristol-Myers Squibb (Switzerland)

Also Known As

Ning, Yuhong, Robert S. Sinkovits, Y Ning, Y. Ning, Yuhong Ning

57

Publications

2.1K

Citations

15

H-Index

23

Concepts

All Affiliations

Bristol-Myers Squibb (Switzerland)California Institute of TechnologyUniversity of California, San FranciscoUCSF Helen Diller Family Comprehensive Cancer CenterID Genomics (United States)
YN

About

Yuhong Ning is an author at Bristol-Myers Squibb (Switzerland) specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

78

2

Cell Biology

2

2

78

3

Health Sciences

1

1

47

4

Biomedical Engineering

1

1

47

5

Blood Transplantation

1

1

47

Yuhong Ning

×

14

Publications

1.9K

Citations

14

H-Index

YearCitations

Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate <scp>T</scp> cells by inducing degradation of <scp>T</scp> cell repressors <scp>I</scp> karos and <scp>A</scp> iolos via modulation of the <scp>E</scp> 3 ubiquitin ligase complex <scp>CRL</scp> 4 <scp> <sup>CRBN</sup> </scp>

Anita K. Gandhi, Jian Kang, Courtney G. Havens,

British Journal of Haematology

2013

611

A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines

Paul W. Hollenbach, Aaron Nguyen, Helen Brady,

PLoS ONE

2010

354

A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation

Xiaolong Cui, Ji Nie, Jeremy Ku,

Nature Communications

2020

213

Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4

Chad C. Bjorklund, Ling Lu, Jian Kang,

Blood Cancer Journal

2015

211

Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA

Gulfem D. Guler, Yuhong Ning, Chin‐Jen Ku,

Nature Communications

2020

177

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Martin Sjöström, Shuang G. Zhao, Samuel Levy,

Cancer Research

2022

61

Pomalidomide in combination with dexamethasone results in synergistic anti‐tumour responses in pre‐clinical models of lenalidomide‐resistant multiple myeloma

Emily Rychak, Derek Mendy, Tao Shi,

British Journal of Haematology

2016

56

Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy

Lin Kang, Vanessa Voskinarian-Berse, Eric Law,

Frontiers in Immunology

2013

47

Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK1/2 Inhibitor for Treatment of Triple-Negative Breast Cancer with a Compromised G1–S Checkpoint

Dan Zhu, Shuichan Xu, Gordafaried Deyanat‐Yazdi,

Molecular Cancer Therapeutics

2018

35

Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA

David Haan, Anna Bergamaschi, Verena Friedl,

Clinical Gastroenterology and Hepatology

2023

31

Page 1